Key result
Tricholoma matsutake peptide inhibits ACE and significantly lowers systolic blood pressure in hypertensive rats.
Hypertension is a major risk factor for cardiovascular disease. A crude water extract of the fruiting bodies of a highly prized mushroom Tricholoma matsutakei exerted an antihypertensive action on spontaneously hypertensive rats (SHRs) at a dosage of 400 mg/kg. An angiotensin converting enzyme (ACE) inhibitory peptide with an IC50 of 0.40 μM was purified from the extract and designated as TMP. Its amino acid sequence was elucidated to be WALKGYK through LC-MS/MS analysis. The Lineweaver-Burk plot suggested that TMP was a non-competitive inhibitor of ACE. A short-term assay of antihypertensive activity demonstrated that TMP at the dosage of 25 mg/kg could significantly lower the systolic blood pressure (SBP) of SHRs. TMP exhibited remarkable stability over a wide range of temperatures and pH values. It also demonstrated 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity. The aforementioned activities of TMP were corroborated by utilizing the synthetic peptide. Hence T. matsutake can be used as a functional food to help prevent hypertension- associated diseases.
No takes yet. Share an insight, caveat, or question.
Geng et al. (2016) studied Hypertension. Tricholoma matsutake peptide (TMP) and crude water extract was evaluated on Systolic blood pressure (SBP) and angiotensin converting enzyme (ACE) inhibition (IC50 0.40 μM). Tricholoma matsutake peptide (TMP) inhibited ACE (IC50 0.40 μM) and at 25 mg/kg significantly lowered systolic blood pressure in spontaneously hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: